Molecular and pathological characterization of inherited breast cancer

Seminars in Cancer Biology

Volumn 11, Issue 5, 2001, Pages 375-385

  Borg, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BRCA1; BRCA2; Breast cancer; Molecular characterization; Pathological characterization

Indexed keywords

BREAST CANCER; FAMILIAL CANCER; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; ONCOGENE; OVARY CANCER; PROTEIN INTERACTION; REVIEW;

EID: 0034751402     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2001.0393     Document Type: Article

References (70)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
4. Population genetics of BRCA1 and BRCA2
5. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
6. Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease
7. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: Linkage analysis in German breast cancer families
8. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
9. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
10. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
11. Germline mutations of the PTEN gene in cowden disease, an inherited breast and thyroid cancer syndrome
12. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
13. After BRCA1 and BRCA2 - What next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer
14. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
15. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
16. Incidence of cancer in 161 families affected by ataxia-telangiectasia
17. In search of the tumour-suppressor functions of BRCA1 and BRCA2
18. Insights into the functions of BRCA1 and BRCA2
19. BRCA1: Exploring the links to transcription
20. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
21. BRCA1 physically and functionally interacts with ATF1
22. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1
23. Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain
24. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
25. Positional cloning of the gene for Nijmegen breakage syndrome
26. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
27. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function
28. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein
29. BRCA1 required for transcription-coupled repair of oxidative DNA damage
30. The RING heterodimer BRCA1-BARD1 is an ubiquitin ligase inactivated by a breast cancer-derived mutation
31. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression
32. Regulation of BRCA1 expression by the Rb-E2F pathway
33. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach
34. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells
35. Identification of a functional nuclear export sequence in BRCA1
36. A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression
37. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1
38. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals
39. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder
40. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers
41. Mutations truncating the EP300 acetylase in human cancers
42. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
43. Relationship between breast histopathology and family history of breast cancer
44. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
45. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer
46. Tumor biological features of BRCA1-induced breast and ovarian cancer
47. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
48. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
49. The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
50. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study
51. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
52. Estrogen receptor expression in breast cancer
53. Breast development and anatomy
54. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
55. Dissociation between steroid receptor expression and cell proliferation in the human breast
56. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
57. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
58. Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome
59. p53 mutations in BRCA1-associated familial breast cancer
60. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability
61. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation
62. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2
63. Gene-expression profiles in hereditary breast cancer
64. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
65. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
66. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
67. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families
68. Estrogens as endogenous genotoxic agents-DNA adducts and mutations
69. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers